FDA's Guidance on Demonstrating Effectiveness: The Importance of Adequate Clinical Investigations and Confirmatory Evidence

TL;DR Summary
The FDA has released a draft guidance for industry titled "Demonstrating Substantial Evidence of Effectiveness Based on One Adequate and Well-Controlled Clinical Investigation and Confirmatory Evidence," which complements previous guidance documents. The guidance aims to provide clarity on how one clinical investigation and confirmatory evidence can meet the substantial evidence requirement for demonstrating effectiveness of drugs and biological products.
- Demonstrating Substantial Evidence of Effectiveness Based on One Adequate and Well-Controlled Clinical Investigation and Confirmatory Evidence FDA.gov
- FDA's single-trial guidance calls for the good, bad and ugly data to support effectiveness FierceBiotech
- FDA's IT Strategy: Unlocking Potential, Leading Transformation FDA.gov
- Software Associated with Prescription Drugs: Opportunities to Enhance Safe and Effective Medication Use FDA.gov
- View Full Coverage on Google News
Reading Insights
Total Reads
0
Unique Readers
26
Time Saved
1 min
vs 2 min read
Condensed
79%
280 → 59 words
Want the full story? Read the original article
Read on FDA.gov